Leah Mursaleen

629 total citations
12 papers, 330 citations indexed

About

Leah Mursaleen is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Medicine. According to data from OpenAlex, Leah Mursaleen has authored 12 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Molecular Medicine. Recurrent topics in Leah Mursaleen's work include Parkinson's Disease Mechanisms and Treatments (6 papers), Curcumin's Biomedical Applications (3 papers) and Conducting polymers and applications (2 papers). Leah Mursaleen is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (6 papers), Curcumin's Biomedical Applications (3 papers) and Conducting polymers and applications (2 papers). Leah Mursaleen collaborates with scholars based in United Kingdom and United States. Leah Mursaleen's co-authors include Mohammed Gulrez Zariwala, Satyanarayana Somavarapu, Richard Wyse, Simon Stott, Kevin McFarthing, Gary Rafaloff, B Noble, Jonathan A. Stamford, Marco A. S. Baptista and Brian Fiske and has published in prestigious journals such as Progress in Neuro-Psychopharmacology and Biological Psychiatry, Antioxidants and Journal of Parkinson s Disease.

In The Last Decade

Leah Mursaleen

12 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leah Mursaleen United Kingdom	11	160	69	68	68	32	12	330
Xuelian Wang China	11	133 0.8×	88 1.3×	109 1.6×	20 0.3×	8 0.3×	35	463
Horia Petre Costin Romania	10	61 0.4×	59 0.9×	105 1.5×	45 0.7×	4 0.1×	32	334
Wenhua Fang China	9	92 0.6×	33 0.5×	127 1.9×	39 0.6×	4 0.1×	38	459
Dongying Yan China	16	67 0.4×	56 0.8×	132 1.9×	107 1.6×	26 0.8×	25	550
Sepideh Safari Iran	13	29 0.2×	72 1.0×	100 1.5×	50 0.7×	26 0.8×	30	382
Florencia González‐Lizárraga Argentina	10	152 0.9×	70 1.0×	89 1.3×	141 2.1×	4 0.1×	16	357
Marcos Freitas Cordeiro Brazil	11	58 0.4×	12 0.2×	75 1.1×	42 0.6×	20 0.6×	21	291
Pedro Chaná‐Cuevas Chile	10	169 1.1×	79 1.1×	58 0.9×	49 0.7×	2 0.1×	33	332
Yuqi Zeng China	8	33 0.2×	39 0.6×	115 1.7×	93 1.4×	54 1.7×	48	326

Countries citing papers authored by Leah Mursaleen

Since Specialization

Citations

This map shows the geographic impact of Leah Mursaleen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leah Mursaleen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leah Mursaleen more than expected).

Fields of papers citing papers by Leah Mursaleen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leah Mursaleen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leah Mursaleen. The network helps show where Leah Mursaleen may publish in the future.

Co-authorship network of co-authors of Leah Mursaleen

This figure shows the co-authorship network connecting the top 25 collaborators of Leah Mursaleen. A scholar is included among the top collaborators of Leah Mursaleen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leah Mursaleen. Leah Mursaleen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Mursaleen, Leah, et al.. (2023). Curcumin and N-Acetylcysteine Nanocarriers Alone or Combined with Deferoxamine Target the Mitochondria and Protect against Neurotoxicity and Oxidative Stress in a Co-Culture Model of Parkinson’s Disease. Antioxidants. 12(1). 130–130. 12 indexed citations

McFarthing, Kevin, Gary Rafaloff, Brian Fiske, et al.. (2023). Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update. Journal of Parkinson s Disease. 13(4). 427–439. 53 indexed citations

McFarthing, Kevin, Gary Rafaloff, Marco A. S. Baptista, et al.. (2022). Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update. Journal of Parkinson s Disease. 12(4). 1073–1082. 72 indexed citations

Mursaleen, Leah, B Noble, Satyanarayana Somavarapu, & Mohammed Gulrez Zariwala. (2021). Micellar Nanocarriers of Hydroxytyrosol Are Protective against Parkinson’s Related Oxidative Stress in an In Vitro hCMEC/D3-SH-SY5Y Co-Culture System. Antioxidants. 10(6). 887–887. 17 indexed citations

Mursaleen, Leah, et al.. (2020). Co-Administration of Iron and a Bioavailable Curcumin Supplement Increases Serum BDNF Levels in Healthy Adults. Antioxidants. 9(8). 645–645. 22 indexed citations

Mursaleen, Leah, et al.. (2020). N-Acetylcysteine Nanocarriers Protect against Oxidative Stress in a Cellular Model of Parkinson’s Disease. Antioxidants. 9(7). 600–600. 34 indexed citations

Mursaleen, Leah, Satyanarayana Somavarapu, & Mohammed Gulrez Zariwala. (2019). Deferoxamine and Curcumin Loaded Nanocarriers Protect Against Rotenone-Induced Neurotoxicity. Journal of Parkinson s Disease. 10(1). 99–111. 34 indexed citations

Mursaleen, Leah, et al.. (2017). Descriptive symptom terminology used by Parkinson’s patients and caregivers. Volume 7. 71–78. 1 indexed citations

Opie-Martin, Sarah, Catherine Ellis, Rachel Burman, et al.. (2017). The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 18(7-8). 569–575. 36 indexed citations

10.

Mursaleen, Leah, et al.. (2017). Attitudes Towards Data Collection, Ownership and Sharing Among Patients with Parkinson’s Disease. Journal of Parkinson s Disease. 7(3). 523–531. 12 indexed citations

11.

Mathur, Soania, et al.. (2016). Challenges of Improving Patient-Centred Care in Parkinson’s Disease. Journal of Parkinson s Disease. 7(1). 163–174. 17 indexed citations

12.

Mursaleen, Leah & Jonathan A. Stamford. (2015). Drugs of abuse and Parkinson's disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 64. 209–217. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact